Notice of Intent to Sole Source- Investigative Services Police Department (Multiple Locations)
ID: FDANOI10282024Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONRockville, MD, 20841, US

NAICS

Police Protection (922120)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/2298f13bc6e847c5824bdcaa4879b816/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), intends to issue sole source contracts for investigative services with several police departments, including East Providence, North Providence, Virginia, West Virginia, Hopkinton, and Kentucky. The objective of this procurement is to engage these law enforcement agencies for specialized investigative work, with each department receiving an individual contract for a period of performance set for 12 months from the award date. This initiative falls under NAICS code 922120 and is authorized by statute 10 USC 2304 (c)(5), indicating that competitive proposals are not being solicited. Interested firms must submit their capability statements by 10:00 a.m. EST on November 12, 2024, to Nina Montgomery at nina.montgomery@fda.hhs.gov to be considered for this opportunity.

    Point(s) of Contact
    Nina Montgomery
    (240) 402-8086
    nina.montgomery@fda.hhs.gov
    Files
    Title
    Posted
    Notice of Intent_10282024.pdf
    The Food and Drug Administration (FDA) is initiating sole source contracts for investigative work with several police departments, including East Providence, North Providence, Virginia, West Virginia, Hopkinton, and Kentucky. Each department will receive an individual contract, and the period of performance is set for 12 months from the award date. This procurement falls under NAICS code 922120 and is authorized by statute 10 USC 2304 (c)(5), indicating the absence of competitive proposals for this solicitation. Interested firms must express their capability within 7 days to be considered. The notice will close on November 12, 2024, at 10 am EST, with responses directed to Nina Montgomery via email. This document underscores the FDA's strategy to streamline procurement processes while engaging specific law enforcement agencies for specialized services.
    Similar Opportunities
    Solicitation: Tobacco Retailer Inspections - 75F40125R00018
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to conduct tobacco retailer inspections across multiple regions in the United States. The primary objective of this procurement is to ensure compliance with federal laws regarding the sale and advertising of tobacco products, particularly focusing on preventing youth access to these products. This initiative is critical for enhancing the FDA's enforcement capabilities and protecting public health by reducing tobacco use among minors. Interested contractors should contact Janice Heard at janice.heard@fda.hhs.gov or Brandon Rafus at brandon.rafus@fda.hhs.gov for further details, with the contract period spanning five years and specific funding amounts to be determined for each region.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    MRC Biosafety Cabinet Evaluation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking qualified small businesses to provide engineering evaluation services for biological safety cabinets (BSCs) at its Center for Veterinary Medicine. The primary objective of this procurement is to assess existing BSCs that are failing to meet certification standards, particularly focusing on their associated HVAC and control systems, and to provide recommendations for replacements. This evaluation is crucial for maintaining laboratory safety and operational efficiency, ensuring compliance with federal safety standards. Interested parties must attend a mandatory site visit on December 17, 2024, and submit their quotations by January 8, 2025, to the contracting officer, Sheneil Green, at Sheneil.Green@fda.hhs.gov.
    Access to Outpatient Longitudinal Drug Utilization Data
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide access to outpatient longitudinal drug utilization data through a Sources Sought notice. The primary objective is to acquire existing, HIPAA-compliant data resources that will enhance drug safety evaluations, support post-market surveillance, and inform regulatory decisions, rather than developing new databases. This initiative is crucial for monitoring medication utilization trends, particularly in areas such as opioid surveillance, and aims to improve public health outcomes through rigorous analyses of drug safety data. Interested firms must submit their responses by January 23, 2025, including their business size status and DUNS number, and can direct inquiries to Telisha Wilson at telisha.wilson@fda.hhs.gov.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Food Applications Regulatory Management (FARM) System
    Active
    Health And Human Services, Department Of
    The U.S. Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information from small businesses capable of providing information technology support services for the Food Applications Regulatory Management (FARM) System as part of its Human Foods Program (HFP). The objective of this Request for Information (RFI) is to identify potential vendors who can enhance ongoing operations, maintenance, and development of various IT systems, ensuring improved workflows, data quality, and comprehensive management of IT operations related to food safety and nutrition. Interested parties are encouraged to submit detailed capability statements that address their relevant experience and solutions by January 13, 2025, and must be appropriately registered to qualify for consideration. For further inquiries, vendors can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov or by phone at 301-796-7376.
    FY25 CTP Docker Desktop Software Licenses
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking quotes for the procurement of 99 Docker Desktop software licenses for its Center for Tobacco Products (CTP). This requirement is part of a firm-fixed-price contract, which will commence on January 15, 2025, and run through January 14, 2026, with options for two additional one-year extensions. The software licenses are essential for enhancing operational efficiency within the CTP, and vendors must comply with Federal Acquisition Regulation (FAR) guidelines, including accessibility standards under Section 508 of the Rehabilitation Act. Interested vendors should submit their quotes by January 13, 2025, and can direct inquiries to Terina Hicks at terina.hicks@fda.hhs.gov or Roosevelt Walker at roosevelt.walker@fda.hhs.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Safe Medication Use
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is conducting a Request for Information (RFI) to identify potential sources capable of providing medication error reports, an analytics platform, and related services aimed at preventing and analyzing medication errors. This initiative, led by the FDA's Center for Drug Evaluation and Research, seeks organizations that can supply nationwide data from healthcare providers, consumers, and patient safety organizations, emphasizing the importance of robust reporting, data analysis, and training in enhancing medication safety protocols. Interested parties, particularly small businesses, are encouraged to submit their capability statements by January 6th, 2025, and should note that responses are voluntary and do not imply a commitment for a contract. For further inquiries, contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov or call 301-796-7376.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.